ABSTRACT Several neuropeptides injected intracisternally were assessed for their effects on gastric secretion in rats.
peptides tested, only 19-endorphin and a potent gonadotropin releasing-factor (gonadoliberin) agonist significantly reduced gastric acid secretion, with an activity ca. 100 times less than that of bombesin. The presence of bombesin-like material in rat brain and the high potency of bombesin to inhibit gastric secretion suggest that this peptide may be of physiologic significance as a chemical messenger involved in brain modulation of gastric secretion. The original observation that discrete brain lesions induced pathological changes in the gastric mucosa (1, 2) focused attention on the role of the central nervous system in the pathophysiological regulation of gastric function. Subsequently, numerous investigators attempted to elucidate brain structures and neurogenic/humoral pathways involved in the control of gastric secretion. In rats, several studies have demonstrated that the hypothalamus influences gastric secretion. Stimulation of the lateral hypothalamus, but not of the surrounding area, caused a vagally mediated increase in acid output (3, 4) . On the other hand, stimulation of the ventromedial hypothalamus decreased acid secretion (3) , whereas lesion experiments had opposite effects (5) . Previous studies of chemical signals participating in the brain modulation of gastric secretion seem to indicate that cholinergic-stimulatory (6) and noradrenergicinhibitory mechanisms play a role (4, 7) .
The presence in mammalian brain of oligopeptides acting in the central nervous system to influence glucoregulation (8, 9) , thermoregulation (10, 11) , blood pressure (12, 13) , sympathetic outflow (9) , and stress-induced gastric hemorrhagic lesions (14) led us to studies designed to assess the roles these peptides may play in brain control of gastric secretion. The results indicate that bombesin*, a tetradecapeptide originally isolated from anurian skin (15) , injected intracerebrally is extraordinarily potent in inhibiting gastric acid secretion.
MATERIALS AND METHODS
Male Sprague-Dawley CD rats (250-300 g), maintained ad lib on Purina Laboratory Chow and tap water, were housed under conditions of controlled temperature and illumination (from 06:00 to 22:00 hr). All experiments were performed according to the same time schedule in 24-hr-food-deprived rats with free access to water up to the beginning of treatment. Rats under light ether anesthesia were injected intracisternally (i.c.) or intracerebroventricularly (i.v.t.) through a permanent cannula implanted into the right lateral brain ventricle a few days before, or intravenously (i.v.) through the jugular vein, with saline or test materials. Immediately after injection, the pylorus portion of the stomach was ligated. The righting reflex was normally regained 5-10 min after surgery, and conscious rats were decapitated 2 hr following pylorus ligation unless otherwise specified. Trunk blood and gastric content were collected separately and centrifuged. Plasma glucose concentrations were determined by the glucose oxidase method with a Beckman glucose analyzer. Gastric secretory volume and pH were measured and samples (0.5 or 1 ml) were analyzed for gastric acidity by titration with 0.01 M sodium hydroxide to a pH of 7.0. A bilateral adrenalectomy or a sham operation was performed immediately before peptide injection and pylorus ligature. Subdiaphragmatic vagotomy by using the general method described by Martin et al. (16) was performed 1 week prior to the experiments.
In some studies, intra-atrial silastic catheters were placed and a permanent cannula was implanted into the right lateral brain Abbreviations: GnRF, gonadotropin releasing-factor (gonadoliberin); i.c., intracisternal(ly); i.v.t., intracerebroventricular(ly); i.v., intravenous(ly); 2-dDG, 2-deoxy-D-glucose. * Bombesin has the following structure: Pyr-Gln-Arg-Leu-Gly-AsnGln-Trp-Ala-Val-Gly-His-Leu-Met-NH2. 175± 42 * = P < 0.05; ** = P < 0.01 as compared with saline-treated rats. Fasted rats (24 hr) under light ether anesthesia were injected intracisternally with saline (10,gl) or peptides (1 tsg/10 pl) and the pylorus was ligated. Two hours later, the animals were decapitated and the gastric secretion was collected.
ventricle as described (17) . After 5-7 days, rats were injected i.v.t. with saline or bombesin. Blood samples were withdrawn before the injection and at 15-min intervals for 1 hr (17). The plasma was separated and frozen for subsequent gastrin determinations, according to the method of Walsh (18) . A guinea pig antiserum to porcine gastrin at the final dilution of 1: 100,000 (provided by John Walsh, UCLA) was used, and synthetic human gastrin-17 was utilized for iodination and as an unlabeled reference standard.
Peptides were synthesized using solid phase methodology (19) . Insulin (Eli Lilly) and 2-deoxy-D-glucose (2-dDG) (Schwarz Bioresearch, Orangeburg, NY) were freshly dissolved in 0.9% saline before use and injected in 10-Al (i.c.) or 0.2-ml
Following analysis of variance, differences between groups were determined by the multiple range test of Dunnett and Duncan by using the computer program EXBIOL. (Fig. 1 ) indicated that the peptide, when given i.c., was very potent in decreasing the volume and titratable acidity of gastric secretion in a dosedependent manner and in increasing pH values with a linear dose-response relationship within the dose range of 10-1000 ng. The minimal effective dose was less than 10 ng (6 pmol). Inhibition of gastric secretion also was observed when bombesin was administered via the lateral ventricle of rat brain (data not shown). By contrast, systemic injection of the peptide, even at doses 104 times higher than that which was effective when administered i.c., had no effect.
RESULTS
The time course of gastric response to a 100-ng dose of bombesin given i.c. is shown in Fig. 2 . pH values are significantly elevated and the volume of secretion is markedly reduced during the first 2 hr following peptide injection; later these parameters become similar to that of saline-treated controls.
The effect of bombesin (1 ,tg i.c.) on gastric acid output stimulated by 2-dDG and insulin is depicted in Fig. 3 . In 2-hr-pylorus-ligated rats, bombesin inhibited gastric acid response to 2-dDG by 70% and to insulin by 55%.
Bombesin injected i.v.t. with a 1-,ug dose (but not with a 100-ng dose) significantly increased plasma levels of gastrin, as measured for 60 min following peptide injection to conscious, chronically (i.v.t. and intra-atrial) cannulated rats (Fig. 4) .
In sham-operated rats, bombesin (1 ,tg Fig. 1 . ** = P < 0.01. glucose levels, reduced the volume of gastric secretion, and suppressed gastric acidity (Table 2) . Adrenalectomy completely prevented the hyperglycemic effect of the peptide but did not abolish its inhibitory action on gastric secretion. Vagotomy did not alter the bombesin-induced rise in pH of gastric secretion (Fig. 5) . Two hours later the rats were decapitated. For other details, see the legend of Fig. 3. effective i.c. In agreement with the latter finding, bombesin administered i.v. or subcutaneously has been reported to have no influence on acid secretion in the perfused preparation of rat stomach (27) , whereas bombesin is a very potent gastric acid releaser in dog or in human (28, 29) . The exact neuroanatomical site of bombesin action, perhaps located in structures known to affect gastric secretions and food intake or those already demonstrated to be the substrate mediating its hypothermic action (30) , is presently unknown.
DISCUSSION
Gastrin and the parasympathetic nervous system are wellestablished stimulatory factors in the control of gastric secretion (6) , and we evaluated if bombesin action involved the inhibition of such humoral/neurogenic pathways. The results show that bombesin action is not mediated through a decrease in gastrin release, because intracerebral injection of the peptide at a 100-ng or 1-pg dose resulted respectively in no change or in an elevation in plasma gastrin levels. The release of gastrin could be related to the rise of gastric pH leading to the removal of gastric acid-mediated inhibition of gastrin secretion. Vagal tone has a critical role in the production of gastric secretion in pylorus-ligated rats (31) , and secretagogues, such as 2-dDG and insulin, act through a cephalic vagal stimulation (32, 33) . The fact that bombesin suppressed basal and insulin-or 2-dDGstimulated gastric secretion in pylorus-ligated rats suggests that the peptide could decrease vagal activity. However, whereas in pylorus-ligated rats vagotomy is well-known to decrease gastric acid secretions (23, 31, present The demonstrated central nervous system-mediated effects of bombesin included the development of a sustained hyperglycemia (8) and hyperglucagonemia (21) , which is adrenaldependent through an increase in sympathetic outflux (8) . Because it has been shown that hyperglycemia (34, 35) , hyperglucagonemia (36, 37), and increased sympathetic outflux (4, 7) singly decrease gastric acid secretion in experimental animals and in humans, we evaluated the influence of bombesin on gastric secretion in the absence of such alterations. It is evident that in adrenalectomized rats, bombesin still produced a significant inhibition in both the acidity and volume of gastric secretion, whereas the hyperglycemia response was abolished (33, present observation). These results support the concept that the effect of bombesin on gastric secretion is not adrenal dependent although the stimulation of adrenomedullar secretion induced by bombesin (8) could contribute in part to the peripheral expression of its antisecretory action. More research is needed to determine the cerebral and peripheral neurogenic/humoral processes through which bombesin injected into the brain induced such alterations of gastric secretion.
These studies raise the question as to whether a bombesin-like substance plays a role in mammalian brain control of gastric secretion. Bombesin is now recognized to have immunologically characterized counterparts in mammalian brain and gastrointestinal tract (38) . Recently, McDonald et al. (39) have isolated from porcine gut a 27-amino acid peptide with the C-terminal decapeptide fragment essentially identical to the C-terminal decapeptide of frog skin bombesin. Such a peptide has been shown to mimic several central nervous systemmediated actions of bombesin on glucoregulation, thermoregulation (40) , and gastric secretion (41) .
Moreover, high-affinity binding sites for bombesin have been characterized in rat brain synaptosomal preparations (42) , and the release of bombesin-like peptide from hypothalamic slices induced by depolarizing stimuli have been reported (43) . The presence of bombesin-like activity in brain tissue and its clear effectiveness at very low doses suggest that this peptide may have physiologic significance as a central nervous system chemical messenger participating in cerebral modulation of gastric secretion.
In conclusion, the demonstration that some oligopeptides are able to act in the central nervous system to influence gastric secretion makes them suitable tools to dissect the cerebral and peripheral control of such function. It also raises the possibility that some of them may participate in the biochemical processes involved in central nervous system regulation of gastric secretion under physiologic and pathologic circumstances.
